Matches in Wikidata for { <http://www.wikidata.org/entity/Q43240420> ?p ?o ?g. }
- Q43240420 description "2009 nî lūn-bûn" @default.
- Q43240420 description "2009年の論文" @default.
- Q43240420 description "2009年学术文章" @default.
- Q43240420 description "2009年学术文章" @default.
- Q43240420 description "2009年学术文章" @default.
- Q43240420 description "2009年学术文章" @default.
- Q43240420 description "2009年学术文章" @default.
- Q43240420 description "2009年学术文章" @default.
- Q43240420 description "2009年學術文章" @default.
- Q43240420 description "2009年學術文章" @default.
- Q43240420 description "2009年學術文章" @default.
- Q43240420 description "2009年學術文章" @default.
- Q43240420 description "2009年學術文章" @default.
- Q43240420 description "2009년 논문" @default.
- Q43240420 description "article científic" @default.
- Q43240420 description "article scientific" @default.
- Q43240420 description "article scientifique" @default.
- Q43240420 description "articol științific" @default.
- Q43240420 description "articolo scientifico" @default.
- Q43240420 description "artigo científico" @default.
- Q43240420 description "artigo científico" @default.
- Q43240420 description "artigo científico" @default.
- Q43240420 description "artikel ilmiah" @default.
- Q43240420 description "artikull shkencor" @default.
- Q43240420 description "artikulong pang-agham" @default.
- Q43240420 description "artykuł naukowy" @default.
- Q43240420 description "artículo científico publicado en 2009" @default.
- Q43240420 description "artículu científicu espublizáu en 2009" @default.
- Q43240420 description "bilimsel makale" @default.
- Q43240420 description "bài báo khoa học" @default.
- Q43240420 description "naučni članak" @default.
- Q43240420 description "scienca artikolo" @default.
- Q43240420 description "scientific article published on 16 November 2009" @default.
- Q43240420 description "scientific article published on 16 November 2009" @default.
- Q43240420 description "scientific article published on 16 November 2009" @default.
- Q43240420 description "teaduslik artikkel" @default.
- Q43240420 description "tieteellinen artikkeli" @default.
- Q43240420 description "tudományos cikk" @default.
- Q43240420 description "vedecký článok" @default.
- Q43240420 description "vetenskaplig artikel" @default.
- Q43240420 description "videnskabelig artikel" @default.
- Q43240420 description "vitenskapelig artikkel" @default.
- Q43240420 description "vitskapeleg artikkel" @default.
- Q43240420 description "vědecký článek" @default.
- Q43240420 description "wetenschappelijk artikel" @default.
- Q43240420 description "wissenschaftlicher Artikel" @default.
- Q43240420 description "επιστημονικό άρθρο" @default.
- Q43240420 description "мақолаи илмӣ" @default.
- Q43240420 description "наукова стаття, опублікована в листопаді 2009" @default.
- Q43240420 description "научна статия" @default.
- Q43240420 description "научная статья" @default.
- Q43240420 description "научни чланак" @default.
- Q43240420 description "научни чланак" @default.
- Q43240420 description "מאמר מדעי" @default.
- Q43240420 description "مقالة علمية نشرت في 16 نوفمبر 2009" @default.
- Q43240420 description "১৬ নভেম্বর ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q43240420 description "บทความทางวิทยาศาสตร์" @default.
- Q43240420 description "სამეცნიერო სტატია" @default.
- Q43240420 name "Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma" @default.
- Q43240420 name "Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma" @default.
- Q43240420 type Item @default.
- Q43240420 label "Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma" @default.
- Q43240420 label "Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma" @default.
- Q43240420 prefLabel "Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma" @default.
- Q43240420 prefLabel "Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma" @default.
- Q43240420 P1433 Q43240420-C302425A-3A3C-454D-8FDE-6FECD5D78D1B @default.
- Q43240420 P1476 Q43240420-20094AD3-CD22-4198-829B-E948548CCC78 @default.
- Q43240420 P2093 Q43240420-2526A0BE-2EE3-43C0-BF19-DF2A7E8398FD @default.
- Q43240420 P2093 Q43240420-2A4EE765-05C5-45D6-8CC1-E5045C142EA5 @default.
- Q43240420 P2093 Q43240420-38698CB6-04C4-421A-94DF-AD9976CF66FB @default.
- Q43240420 P2093 Q43240420-4BBFC916-D7C1-4A88-AB3F-75F72FCECB63 @default.
- Q43240420 P2093 Q43240420-7EA98E76-212C-49B5-B90D-CF174C84E93B @default.
- Q43240420 P2093 Q43240420-8B4FF1FC-3AFC-4B69-87D3-223FE8D2ECD0 @default.
- Q43240420 P2093 Q43240420-9360D91D-923D-4DFB-9FC6-3A3772885F73 @default.
- Q43240420 P2093 Q43240420-94991C1A-9DB6-4300-8923-B7D9C2DDEC6C @default.
- Q43240420 P2093 Q43240420-979FDBAE-ECD2-4126-824C-6C0257384C26 @default.
- Q43240420 P2093 Q43240420-A8F0400A-6FD0-4091-B18D-6FDD16F73404 @default.
- Q43240420 P2093 Q43240420-AA3D7C2B-A0EA-4AB4-9271-3CE14CEBCB02 @default.
- Q43240420 P2093 Q43240420-AD63E31A-2140-4FD6-8290-CC9C82F3F668 @default.
- Q43240420 P2093 Q43240420-C1A06159-1198-4C1E-BB45-CEFF00C2F6A9 @default.
- Q43240420 P2093 Q43240420-DD37B519-66FE-4988-B663-00B05EB2ACDD @default.
- Q43240420 P304 Q43240420-53D1AC2B-4D1A-42AD-8FD0-F94C7AD3B592 @default.
- Q43240420 P31 Q43240420-F2FAD510-5447-408D-8737-3BF6F9A77BE9 @default.
- Q43240420 P356 Q43240420-16CA0081-448E-4BEF-8017-39DC9B0E8A06 @default.
- Q43240420 P407 Q43240420-0BA7F426-412F-4172-BE9E-C44254C1BED8 @default.
- Q43240420 P433 Q43240420-8C523F36-4EA4-47A9-9216-964B8F8432A8 @default.
- Q43240420 P478 Q43240420-FB4FAC2C-F0CB-4DA4-AD66-8E6D9EF7D2AA @default.
- Q43240420 P50 Q43240420-582EDF24-5F8E-43A3-9B8A-0450A17D13B2 @default.
- Q43240420 P577 Q43240420-A9EC81F1-E595-4C10-836D-A8B82BB16BEF @default.
- Q43240420 P5875 Q43240420-863F4C57-2127-4F3B-9455-8CDD158E42D8 @default.
- Q43240420 P698 Q43240420-A00C113F-3C23-4A88-9AAD-B9B39FC35651 @default.
- Q43240420 P921 Q43240420-1DEAFC5F-AA51-44CE-82FB-755C4B6B2EF7 @default.
- Q43240420 P921 Q43240420-47A2EBF9-277B-4ECE-A0C4-379440DB2E88 @default.
- Q43240420 P356 J.1365-2141.2009.07981.X @default.
- Q43240420 P698 19919652 @default.
- Q43240420 P1433 Q4970200 @default.
- Q43240420 P1476 "Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma" @default.
- Q43240420 P2093 "Amitabha Mazumder" @default.
- Q43240420 P2093 "David H Vesole" @default.
- Q43240420 P2093 "David Irwin" @default.